DOUGLAS FAMBROUGH Insider Trading $DRNA Dicerna Pharmaceuticals Inc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DOUGLAS FAMBROUGH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DOUGLAS FAMBROUGH. DOUGLAS FAMBROUGH is Director in Solexa, Inc. ($LYNX) and Chief Executive Officer in Dicerna Pharmaceuticals Inc ($DRNA) and President and CEO in Dicerna Pharmaceuticals Inc ($DRNA).
DOUGLAS FAMBROUGH in Dicerna Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DOUGLAS FAMBROUGH: President and CEO, Chief Executive Officer
Holdings: 43,189 shares
Current Value: $111,428
Latest Transaction: Jan 12 2021
$DRNA Market Capitalization: $50.84M
$DRNA Previous Close: $2.58
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DOUGLAS FAMBROUGH in Dicerna Pharmaceuticals Inc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12 2021 | DRNA | Dicerna Pharmaceut ... | FAMBROUGH DOUGLAS | President and CEO | Option Exercise | A | 24.05 | 247,700 | 5,957,185 | 247,700 | |
| Jan 12 2021 | DRNA | Dicerna Pharmaceut ... | FAMBROUGH DOUGLAS | President and CEO | Option Exercise | A | 0.00 | 55,000 | 0 | 55,000 | |
| Jan 12 2021 | DRNA | Dicerna Pharmaceut ... | FAMBROUGH DOUGLAS | President and CEO | Option Exercise | M | 0.00 | 19,950 | 0 | 59,850 | |
| Jan 12 2021 | DRNA | Dicerna Pharmaceut ... | FAMBROUGH DOUGLAS | President and CEO | Payment of Exercise | F | 23.29 | 6,159 | 143,443 | 37,030 | 43.2 K to 37 K (-14.26 %) |
| Jan 12 2021 | DRNA | Dicerna Pharmaceut ... | FAMBROUGH DOUGLAS | President and CEO | Buy | M | 0.00 | 19,950 | 0 | 43,189 | 23.2 K to 43.2 K (+85.85 %) |
| Sep 01 2020 | DRNA | Dicerna Pharmaceut ... | FAMBROUGH DOUGLAS | President and CEO | Buy | P | 18.06 | 10,000 | 180,597 | 22,300 | 12.3 K to 22.3 K (+81.30 %) |
| Jan 10 2020 | DRNA | Dicerna Pharmaceut ... | FAMBROUGH DOUGLAS | Chief Executive Off ... | Option Exercise | A | 22.58 | 250,000 | 5,645,000 | 250,000 | |
| Jan 10 2020 | DRNA | Dicerna Pharmaceut ... | FAMBROUGH DOUGLAS | Chief Executive Off ... | Option Exercise | A | 0.00 | 79,800 | 0 | 79,800 | |
| Dec 19 2019 | DRNA | Dicerna Pharmaceut ... | FAMBROUGH DOUGLAS | Chief Executive Off ... | Option Exercise | M | 3.42 | 80,000 | 273,600 | 201,250 | |
| Dec 19 2019 | DRNA | Dicerna Pharmaceut ... | FAMBROUGH DOUGLAS | Chief Executive Off ... | Sell | S | 27.07 | 1,431 | 38,742 | 12,300 | 13.7 K to 12.3 K (-10.42 %) |
| Dec 19 2019 | DRNA | Dicerna Pharmaceut ... | FAMBROUGH DOUGLAS | Chief Executive Off ... | Option Exercise | M | 3.42 | 80,000 | 273,600 | 201,250 | |
| Dec 19 2019 | DRNA | Dicerna Pharmaceut ... | FAMBROUGH DOUGLAS | Chief Executive Off ... | Sell | S | 25.85 | 78,569 | 2,030,844 | 13,731 | 92.3 K to 13.7 K (-85.12 %) |
| Dec 19 2019 | DRNA | Dicerna Pharmaceut ... | FAMBROUGH DOUGLAS | Chief Executive Off ... | Sell | S | 27.07 | 1,431 | 38,742 | 12,300 | 13.7 K to 12.3 K (-10.42 %) |
| Dec 19 2019 | DRNA | Dicerna Pharmaceut ... | FAMBROUGH DOUGLAS | Chief Executive Off ... | Buy | M | 3.42 | 80,000 | 273,600 | 92,300 | 12.3 K to 92.3 K (+650.41 %) |
| Dec 19 2019 | DRNA | Dicerna Pharmaceut ... | FAMBROUGH DOUGLAS | Chief Executive Off ... | Sell | S | 25.85 | 78,569 | 2,030,844 | 13,731 | 92.3 K to 13.7 K (-85.12 %) |
| Dec 19 2019 | DRNA | Dicerna Pharmaceut ... | FAMBROUGH DOUGLAS | Chief Executive Off ... | Sell | S | 26.94 | 2,305 | 62,107 | 12,300 | 14.6 K to 12.3 K (-15.78 %) |
| Dec 19 2019 | DRNA | Dicerna Pharmaceut ... | FAMBROUGH DOUGLAS | Chief Executive Off ... | Buy | M | 3.42 | 80,000 | 273,600 | 92,300 | 12.3 K to 92.3 K (+650.41 %) |
| Dec 19 2019 | DRNA | Dicerna Pharmaceut ... | FAMBROUGH DOUGLAS | Chief Executive Off ... | Sell | S | 26.13 | 56,716 | 1,482,239 | 14,605 | 71.3 K to 14.6 K (-79.52 %) |
| Dec 19 2019 | DRNA | Dicerna Pharmaceut ... | FAMBROUGH DOUGLAS | Chief Executive Off ... | Sell | S | 26.94 | 2,305 | 62,107 | 12,300 | 14.6 K to 12.3 K (-15.78 %) |
| Dec 19 2019 | DRNA | Dicerna Pharmaceut ... | FAMBROUGH DOUGLAS | Chief Executive Off ... | Sell | S | 26.13 | 56,716 | 1,482,239 | 14,605 | 71.3 K to 14.6 K (-79.52 %) |
| Jan 04 2019 | DRNA | Dicerna Pharmaceut ... | FAMBROUGH DOUGLAS | Chief Executive Off ... | Option Exercise | A | 11.77 | 505,000 | 5,943,850 | 505,000 | |
| Jan 08 2018 | DRNA | Dicerna Pharmaceut ... | FAMBROUGH DOUGLAS | Chief Executive Off ... | Option Exercise | A | 9.30 | 255,000 | 2,371,500 | 255,000 | |
| Jan 05 2017 | DRNA | Dicerna Pharmaceut ... | FAMBROUGH DOUGLAS | Chief Executive Off ... | Option Exercise | A | 2.97 | 225,000 | 668,250 | 225,000 | |
| Nov 16 2016 | DRNA | Dicerna Pharmaceut ... | FAMBROUGH DOUGLAS | Chief Executive Off ... | Buy | P | 3.63 | 16,500 | 59,895 | 55,579 | 39.1 K to 55.6 K (+42.22 %) |
| Nov 16 2016 | DRNA | Dicerna Pharmaceut ... | FAMBROUGH DOUGLAS | Chief Executive Off ... | Buy | P | 3.78 | 16,600 | 62,748 | 39,079 | 22.5 K to 39.1 K (+73.85 %) |
| Jan 12 2016 | DRNA | Dicerna Pharmaceut ... | FAMBROUGH DOUGLAS | Chief Executive Off ... | Option Exercise | A | 9.09 | 225,000 | 2,045,250 | 225,000 |
Page: 1